The catechol-O-methyltransferase (COMT), which is involved in dopamine metabolism, exhibits low promoter methylation correlated with increased gene expression, especially in male patients, suggesting an elevated schizophrenia risk (Gao et al., 2017; Figure 6B). The gene discussed is COMT; the disease is schizophrenia.